0000000000777592

AUTHOR

Jy Kim

showing 4 related works from this author

Combined Analysis of Neutrino and Antineutrino Oscillations at T2K.

2017

T2K reports its first results in the search for CP violation in neutrino oscillations using appearance and disappearance channels for neutrino- and antineutrino-mode beams. The data include all runs from January 2010 to May 2016 and comprise 7.482 ×10^(20) protons on target in neutrino mode, which yielded in the far detector 32 e-like and 135 μ-like events, and 7.471 × 10^(20) protons on target in antineutrino mode, which yielded 4 e-like and 66 μ-like events. Reactor measurements of sin(2)2θ(13) have been used as an additional constraint. The one-dimensional confidence interval at 90% for the phase δCP spans the range (−3.13, −0.39) for normal mass ordering. The CP conservation hypothesis …

Particle physicsGeneral PhysicsNeutrino oscillations; CP violation; Neutrino detectors530 PhysicsPhysics MultidisciplinaryFOS: Physical sciencesGeneral Physics and Astronomy01 natural sciences7. Clean energy09 EngineeringHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)Physics and Astronomy (all)0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Neutrino detectors010306 general physicsNeutrino oscillationGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)01 Mathematical SciencesComputingMilieux_MISCELLANEOUSQCPhysicsScience & Technology02 Physical Sciences010308 nuclear & particles physicshep-exNeutrino oscillationsPhysicsCP violationNeutrino detectorantineutrino oscillationsT2K CollaborationPhysical SciencesCP violationNeutrinoPhysical review letters
researchProduct

Observation of Electron Neutrino Appearance in a Muon Neutrino Beam

2014

The T2K experiment has observed electron neutrino appearance in a muon neutrino beam produced 295 km from the Super-Kamiokande detector with a peak energy of 0.6 GeV. A total of 28 electron neutrino events were detected with an energy distribution consistent with an appearance signal, corresponding to a significance of 7.3$\sigma$ when compared to 4.92 $\pm$ 0.55 expected background events. In the PMNS mixing model, the electron neutrino appearance signal depends on several parameters including three mixing angles $\theta_{12}$, $\theta_{23}$, $\theta_{13}$, a mass difference $\Delta m^2_{32}$ and a CP violating phase $\delta_{\mathrm{CP}}$. In this neutrino oscillation scenario, assuming $…

General PhysicsParticle physicsSolar neutrinoPhysics MultidisciplinaryFOS: Physical sciencesGeneral Physics and Astronomy7. Clean energy09 EngineeringHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)Tau neutrino[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Neutrino oscillation01 Mathematical SciencesPhysicsScience & Technology02 Physical Scienceshep-exPhysicsHigh Energy Physics::PhenomenologyT2K experimentFísicaSolar neutrino problemNeutrino detectorT2K CollaborationPhysical SciencesMeasurements of neutrino speedHigh Energy Physics::ExperimentNeutrino
researchProduct

Characterization of nuclear effects in muon-neutrino scattering on hydrocarbon with a measurement of final-state kinematics and correlations in charg…

2018

This paper reports measurements of final-state proton multiplicity, muon and proton kinematics, and their correlations in charged-current pionless neutrino interactions, measured by the T2K ND280 near detector in its plastic scintillator (C$_8$H$_8$) target. The data were taken between years 2010 and 2013, corresponding to approximately 6$\times10^{20}$ protons on target. Thanks to their exploration of the proton kinematics and of kinematic imbalances between the proton and muon kinematics, the results offer a novel probe of the nuclear-medium effects most pertinent to the (sub-)GeV neutrino-nucleus interactions that are used in accelerator-based long-baseline neutrino oscillation measureme…

Fermi gasProtoninteraction: modelPhysics and Astronomy (miscellaneous)Physics::Instrumentation and DetectorsKinematicsKAMIOKANDE7. Clean energy01 natural sciencesPhysics Particles & Fieldscharged currentHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Particle Physics ExperimentsMuon neutrinoneutrino oscillationAXISNuclear ExperimentHigh Energy Physics - Experiment; High Energy Physics - Experiment; Physics and Astronomy (miscellaneous)Charged currentneutrino: interactionPhysicsCHALLENGESPhysicsJ-PARC Labp: final state3. Good healthtransversekinematicsPhysical SciencesNeutrinospectral representationFOS: Physical sciencesddc:500.2Astronomy & AstrophysicsREGIONNuclear physicsphase spacenear detectormuon0103 physical sciencesEXCITATIONddc:530010306 general physicsNeutrino oscillationDETECTORnuclear matter effectscintillation counterp: multiplicityMuonScience & Technology010308 nuclear & particles physicshep-exnucleusscatteringnuclear matter: effectneutrino nucleus: interactionfinal-state interactionneutrino/mu: secondary beamPhase spacecorrelationPhysics::Accelerator Physicsneutrino nucleus interactionneutrino: oscillationexperimental results
researchProduct

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism

2013

BackgroundWhether the oral factor Xa inhibitor edoxaban can be an alternative to warfarin in patients with venous thromboembolism is unclear. MethodsIn a randomized, double-blind, noninferiority study, we randomly assigned patients with acute venous thromboembolism, who had initially received heparin, to receive edoxaban at a dose of 60 mg once daily, or 30 mg once daily (e.g., in the case of patients with creatinine clearance of 30 to 50 ml per minute or a body weight below 60 kg), or to receive warfarin. Patients received the study drug for 3 to 12 months. The primary efficacy outcome was recurrent symptomatic venous thromboembolism. The principal safety outcome was major or clinically re…

MESH: Pulmonary EmbolismMale[SDV]Life Sciences [q-bio]Kaplan-Meier Estimate030204 cardiovascular system & hematologylaw.inventionMESH: Venous Thromboembolismchemistry.chemical_compound0302 clinical medicineRandomized controlled trialEdoxabanlawMESH: Double-Blind Method030212 general & internal medicineMESH: WarfarinMESH: AgedMESH: Middle AgedHazard ratioGeneral MedicineVenous ThromboembolismMiddle AgedThrombosis3. Good healthPulmonary embolismAnesthesiaFemaleAnticoagulants EdoxabanMESH: HemorrhageAndexanet alfamedicine.drugMESH: EnoxaparinHemorrhageMESH: AnticoagulantsMESH: Drug Administration ScheduleDrug Administration Schedule03 medical and health sciencesDouble-Blind MethodAged; Anticoagulants; Double-Blind Method; Drug Administration Schedule; Enoxaparin; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pulmonary Embolism; Venous Thromboembolism; WarfarinmedicineHumansEnoxaparinAdverse effectMESH: Kaplan-Meier EstimateAgedMESH: Humansbusiness.industryWarfarinAnticoagulantsmedicine.diseaseMESH: MalechemistryWarfarinbusinessPulmonary EmbolismMESH: FemaleNew England Journal of Medicine
researchProduct